- About Us
- Nano-Social Network
- Nano Consulting
- My Account
Raymor Penetrates the Metal Injection Molding (MIM) Market
with its Titanium Powder
Montreal | June 22, 2005
Raymor Industries Inc. is proud to announce that its wholly-owned subsidiary,
AP&C Advanced Powders and Coatings Inc. has concluded an agreement for the production of titanium powder
with Metaor (US). Metaor, part of IMC (International Metalworking Companies), specializes in the fabrication of
metal components using a metal injection molding (MIM) process. Their products serve high-volume markets in
various sectors, including automotive, medical, industrial tooling, electronics, and other sectors. Metaor has sales
offices in the US and Europe.
AP&C’s metallic powders are produced using the patented plasma atomization process. This unique process produces metallic powders of high purity, with an exceptional sphericity. Given these two characteristics, AP&C metallic powders offer the best performance for metal injection molding applications. The plasma atomization process was developed at the beginning of the 90’s at Hydro-Quebec’s Shawinigan laboratory, in collaboration with Noranda. AP&C benefits from a worldwide, exclusive license for the process.
“The exceptional sphericity and purity characterisitics of our titanium powers allows us to respond favourably to the strict requirements of the biomedical and aerospace fields,” said Dr. Michel Drouet, Chief Scientist with AP&C. “This agreement with Metaor confirms that our metallic powders meet the needs of the MIM industry, MIM being a method to fabricate complex components using high-value metals,” said Mr. Stéphane Robert, President of Raymor and AP&C. “The use of MIM is advantageous for markets such at aerospace and other specialized sectors, which for us, will imply important powder sales,” added Mr. Robert.
AP&C’s plasma atomization process allows for the commercialization of many types of micron-sized and nanosized metallic powders for different applications in promising markets. With other negotiations underway, AP&C foresees the installation of a second reactor in its facility, which could hold up to six units. The forecasted revenue from powder sales is in the order of $3.5 million per year, per reactor.
About Raymor Industries:
Raymor Industries Inc., (TSX-V:RAR) has as its mission to become the leading Canadian developer of high technology and a producer/recycler of advanced materials and nanomaterials for high value-added applications. In November 2004, Raymor Industries created a wholly-owned, industrial subsidiary, AP&C Advanced Powders and Coatings, specializing in nanotechnology and advanced materials, and comprising four operational divisions: (1) nanotechnology products, including nano-powders, nano-coatings, and single-walled carbon nanotubes (C-SWNT) for “the applications of tomorrow”; (2) metal and ceramic coatings, which largely targets aerospace, military, and mining applications; (3) spherical metallic powders, primarily used for biomedical and aerospace applications; and (4) net-shape forming, a component manufacturing technique used for ballistic protection and other aerospace and military applications. Raymor holds the exclusive rights to more than 20 patents throughout the world, with other patents pending.
For additional information, visit www.raymor.com
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
Molecular phenomenon discovered by advanced NMR facility: Cutting edge technology has shown a molecule self-assembling into different forms when passing between solution state to solid state, and back again - a curious phenomenon in science - says research by the University of Wa February 22nd, 2017
Dream Chip Technologies Presents First 22nm FD-SOI Silicon of New Automotive Driver Assistance SoC: Advanced driver assistance system (ADAS) computer vision SoC developed for European THINGS2DO project with working first silicon fabricated on GLOBALFOUNDRIES’ 22nm FD-SOI Platfor February 27th, 2017
New nano approach could cut dose of leading HIV treatment in half February 24th, 2017